By Jan M. Olsen
A far-right Norwegian lawmaker said Wednesday that he has nominated U.S. President Donald Trump for the Nobel Peace Prize for his efforts in the Middle East.
Christian Tybring-Gjedde, a member of the Norwegian Parliament for the far-right Progress Party, said Trump should be considered because of his work “for a peace agreement between the United Arab Emirates and Israel which opens up for possible peace in the Middle East.”
“No matter how Trump acts at home and what he says at press conferences, he has absolutely a chance at getting the Nobel Peace Prize,” Tybring-Gjedde, told The Associated Press.
He said he nominated Trump on Wednesday, adding that “Donald Trump meets the criteria” for the Nobel Peace Prize.
Tybring-Gjedde was also one of two Norwegian lawmakers who nominated Trump for the peace prize in 2018 for his efforts to bring reconciliation between North and South Korea.
Any national lawmaker can nominate someone for the Nobel Peace Prize.
The process of considering candidates and awarding the prize is done in Norway, in contrast to the other Nobel Prizes, which are awarded in neighboring Sweden. Nominations must be sent to the Norwegian Nobel Committee by Feb. 1.
The Norwegian Nobel Committee doesn’t publicly comment on nominees. Under its rules, the information is required to be kept secret for 50 years.
“It is now to hope that the Nobel Committee is able to consider what Trump has achieved internationally and that it does not stumble in established prejudice against the US President,” Tybring-Gjedde said in a Facebook post.
President Joe Biden says the U.S. expects to take delivery of enough coronavirus vaccines for all adult Americans by the end of May, two months earlier than anticipated.
State Representative Marcus C. Evans, Jr. from Chicago filed amendments to an Illinois bill that would further ban games considered to be too violent from reaching the hands of minors.
Texas is lifting a COVID-19 mask mandate that was imposed last summer but has only been lightly enforced. Republican Gov. Greg Abbott’s announcement Tuesday makes Texas the largest state to do away with a face covering order.
Drugmaker Merck & Co. will help produce rival Johnson & Johnson’s newly approved coronavirus vaccine in an effort to expand supply more quickly.
Calls for New York Gov. Andrew Cuomo to resign are intensifying now that a third woman has accused him of offensive behavior.
The pill comprises 40% of the profits in the U.S. contraceptive market and 25% of contraceptive consumers, causing millions of unnecessary ‘periods’ along the way. So, why hasn’t birth control evolved beyond the pseudo-period?
This is your Washington Week Ahead for the week of March 1.
U.S. health advisers have endorsed a one-dose COVID-19 vaccine from Johnson & Johnson that's expected to provide an easier-to-use option to fight the pandemic.
Following the Senate Intelligence Committee hearing on the widespread SolarWinds cyberattack, cybersecurity experts are pushing the need for private businesses and federal agencies to cooperate closely to prevent future such breaches.
From Wall Street to Silicon Valley, these are the top stories that moved markets and had investors, business leaders, and entrepreneurs talking this week on Cheddar.
